Lymphoma & Plasma Cell Disorders


Bortezomib may overcome resistance in WM

Bortezomib may help overcome treatment resistance in patients with Waldenström’s macroglobulinemia (WM) and CXCR4 mutations, according to a new...

Conference Coverage

CLL: The initial work-up

CHICAGO – Molecular testing has prognostic value, but still doesn’t drive treatment under updated iwCLL guidelines.